CSL +2.1%: Healthcare Outperforms in Risk-Off ASX Day
CSL Limited (CSL) added $7.10 to $352.14, driving the Healthcare sector +2.06% — the ASX's best-performing sector by a wide margin on September 4. CSL's plasma and biotherapeutics business is fundamentally defensive: earnings don't correlate with Chinese PMI or global commodity cycles, making it the natural shelter when iron ore sentiment sours. With Motley Fool Australia flagging passive-income investors earning 18% yields via structured ASX positions, the broader retail investor base is rotating toward predictable dividend payers and high-quality healthcare names when commodity sentiment deteriorates.
Read at Motley Fool Australia ↗